DIPG-35. BIOLOGICAL MEDICINE FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) ERADICATION: RESULTS OF THE THREE ARM BIOMARKER-DRIVEN RANDOMIZED BIOMEDE 1.0 TRIAL

Despite 50 years of clinical trials, no improvement of survival has been observed in DIPG and most children die within 2 years of diagnosis. Only radiotherapy transiently controls disease progression. The study was conceived as a randomized multi-arm multi-stage program. It started with an open-labe...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Grill, Jacques, Teuff, Gwenael Le, Nysom, Karsten, Blomgren, Klas, Hargrave, Darren, MacCowage, Geoff, Bautista, Francisco, Van Vuurden, Dannis, Dangouloff-Ros, Volodia, Puget, Stephanie, Varlet, Pascale, Debily, Marie-Anne, Vassal, Gilles, Deley, Marie-Cecile Le
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Diffuse Midline Glioma/DIPG
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715776/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.083
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料